Gilead Sciences reported $74.66B in Market Capitalization this March of 2022, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Abbvie ABBV:US $ 286.33B 46.96B
Acorda Therapeutics ACOR:US $ 0.02B 0.01B
Agios Pharmaceuticals AGIO:US $ 1.59B 0.19B
Alnylam Pharmaceuticals ALNY:US $ 19.71B 0.57B
Amgen AMGN:US $ 129.08B 2.36B
Biogen BIIB:US $ 30.95B 4.29B
Biomarin Pharmaceutical BMRN:US $ 14.26B 1.96B
Bluebird Bio BLUE:US $ 0.35B 0.35B
Bristol Myers Squibb BMY:US $ 155.49B 17.09B
Coherus Biosciences CHRS:US $ 1B 0.23B
Eli Lilly And LLY:US $ 272.72B 8.49B
Gilead Sciences GILD:US $ 74.66B 16.42B
GlaxoSmithKline GSK:LN 83.74B 2.9B
Glaxosmithkline GSK:US 109.98B 0.61B
Intercept Pharmaceuticals ICPT:US $ 0.48B 0B
Merk MRK:US $ 207.45B 13.86B
Moderna Inc MRNA:US $ 69.42B 33.55B
Novartis NOVN:VX 197.8B 2.36B
Sangamo Biosciences SGMO:US $ 0.85B 0.24B
Sanofi SAN:FP 111.92B 6.96B
Teva Pharmaceutical Industries TEVA:US 10.29B 0.72B
United Therapeutics UTHR:US $ 8.12B 1.61B
YTE INCY:US $ 17.58B 1.36B